▁Chron 10.375
ic 5.49609375
▁pain 11.6953125
▁is 5.5546875
▁still 6.25390625
▁considered 5.03125
▁to 1.7314453125
▁be 0.4521484375
▁an 3.0078125
▁extreme 5.94921875
▁issue 7.3828125
▁among 7.328125
▁at 6.82421875
▁ 4.84765625
8 3.078125
% 4.109375
▁least 7.56640625
▁of 3.390625
▁residents 10.734375
▁of 3.89453125
▁the 2.3828125
▁progress 7.78515625
ive 1.78515625
▁countries 8.484375
. 2.27734375
▁introduction 12.4453125
▁The 6.4140625
▁the 6.046875
▁of 4.98828125
▁study 7.01171875
▁the 2.828125
▁describes 10.328125
▁apparent 11.453125
▁link 8.3359375
▁pain 9.7265625
▁between 3.12890625
▁and 3.98828125
▁dem 8.71875
oral 4.11328125
ization 0.6162109375
. 2.765625
▁Chron 6.65625
ic 0.02032470703125
▁is 4.67578125
▁always 6.62890625
▁pain 3.568359375
▁accompanied 7.7578125
▁by 0.51318359375
▁negative 6.015625
▁emot 2.5703125
ional 1.4091796875
▁experiences 4.00390625
▁a 6.1484375
▁and 4.5703125
▁blocks 11.09375
▁person 8.1796875
’ 22.984375
s 4.17578125
▁ability 4.24609375
▁to 0.63525390625
▁receive 6.3125
▁joy 5.2265625
▁and 1.80859375
▁satisfaction 3.298828125
▁from 1.3193359375
▁life 1.7763671875
. 0.60791015625
▁The 2.58203125
▁research 4.57421875
▁the 4.01953125
▁of 3.03125
▁development 7.8046875
▁investig 8.5546875
ates 0.9736328125
▁de 7.04296875
pression 0.44921875
▁and 1.6787109375
▁anx 3.80859375
iety 0.0085296630859375
▁among 3.560546875
▁patients 4.94140625
▁receiving 3.94921875
▁ph 6.82421875
arma 1.2109375
ce 0.0220794677734375
ut 0.0027751922607421875
ical 0.0250244140625
▁op 4.75
io 0.30078125
ids 1.2021484375
▁and 2.7421875
▁medical 5.0859375
▁mar 1.296875
iju 0.036163330078125
ana 0.0006351470947265625
▁( 4.8359375
MM 1.2548828125
) 2.845703125
▁severe 11.328125
▁as 5.9765625
▁pain 3.826171875
kill 6.49609375
ers 0.00457000732421875
. 1.5634765625
▁It 4.1875
▁the 4.28125
▁comp 7.65234375
ares 0.47509765625
▁effic 8.34375
acy 0.011505126953125
▁of 0.82861328125
▁and 3.310546875
▁pres 8.0
cri 0.57421875
ptions 1.4580078125
▁exam 9.765625
ines 0.39697265625
▁the 1.58203125
▁of 3.28515625
▁possibility 8.1015625
▁post 9.3046875
- 0.76513671875
tre 3.302734375
at 0.02496337890625
ment 0.0276031494140625
▁de 3.091796875
pression 0.13330078125
. 2.248046875
<0x0A> 2.61328125
There 5.0703125
▁is 1.2548828125
▁currently 4.828125
▁a 1.923828125
▁severe 5.48046875
▁lack 2.720703125
▁of 0.10626220703125
▁about 9.859375
▁information 4.046875
▁the 3.923828125
▁effects 7.3203125
▁They 12.484375
▁of 2.58203125
▁op 2.697265625
i 4.46484375
ates 0.11383056640625
. 3.30078125
▁manage 12.7578125
▁successfully 9.796875
, 3.650390625
▁pain 3.884765625
▁the 3.916015625
▁past 8.4140625
▁but 6.7109375
▁few 5.41796875
▁dec 7.66015625
ades 0.0147552490234375
▁indicated 9.9375
▁the 2.07421875
▁growing 6.1484375
▁concern 4.0390625
▁regarding 4.07421875
▁op 2.587890625
iate 0.8662109375
▁ab 1.451171875
use 0.01458740234375
▁in 3.14453125
▁forms 10.4296875
▁of 1.1630859375
▁over 4.64453125
d 0.66552734375
ose 0.1673583984375
▁and 1.1923828125
▁add 1.837890625
iction 0.0284881591796875
. 0.39306640625
▁A 4.265625
▁more 5.37890625
▁manage 7.9375
able 0.2301025390625
▁and 2.201171875
▁sa 4.26953125
fer 0.0005736351013183594
▁alternative 3.017578125
▁might 6.75390625
▁be 0.57568359375
▁medical 3.796875
▁the 3.62109375
▁However 8.2421875
, 0.1468505859375
▁mar 4.0859375
iju 0.00669097900390625
ana 0.002140045166015625
. 5.8359375
▁legal 7.18359375
▁status 6.9296875
▁and 3.208984375
▁of 5.22265625
▁novel 9.7421875
ty 7.04296875
▁drug 6.59375
▁this 7.21875
▁do 8.140625
▁not 2.88671875
▁finding 12.3359375
▁allow 8.9765625
▁a 4.17578125
▁number 4.94140625
▁large 9.8359375
▁of 2.48046875
▁studies 3.908203125
▁on 3.095703125
▁its 2.818359375
▁effect 3.26171875
iveness 0.4072265625
. 1.451171875
▁it 5.453125
▁concerns 8.171875
▁Specifically 10.6171875
, 0.31201171875
▁the 1.6455078125
▁emot 8.78125
ional 0.047119140625
▁condition 6.98046875
▁of 1.2041015625
▁patients 1.97265625
▁experien 5.9140625
cing 0.0017452239990234375
▁chron 1.8876953125
ic 0.003566741943359375
▁pain 0.4501953125
. 3.103515625
▁This 3.458984375
▁research 3.57421875
▁a 4.2109375
ims 1.5869140625
▁paper 10.609375
▁to 1.6025390625
▁analyze 4.25390625
▁levels 9.1015625
▁de 5.34765625
pression 0.1104736328125
▁of 4.9296875
▁and 2.86328125
▁anx 1.5400390625
iety 0.0062103271484375
▁people 7.34375
▁among 5.453125
▁receiving 6.06640625
▁ther 7.10546875
apy 0.39404296875
▁by 4.51953125
▁comparing 6.03515625
▁the 1.42578125
▁effects 2.525390625
▁of 0.3251953125
▁ph 3.390625
arma 0.08270263671875
ce 0.006427764892578125
ut 0.0012712478637695312
ical 0.0044097900390625
▁op 0.497314453125
io 0.12353515625
ids 0.1375732421875
▁MM 6.140625
. 1.5625
<0x0A> 1.6240234375
The 1.703125
▁and 6.23828125
▁was 6.3984375
▁study 6.38671875
▁conducted 3.259765625
▁in 2.123046875
▁the 1.787109375
▁form 5.47265625
▁of 0.345703125
▁collection 9.4609375
▁and 2.21875
▁analysis 0.947265625
▁of 0.193359375
▁statistical 4.60546875
▁data 0.20458984375
. 1.310546875
▁Part 5.12109375
icip 0.0914306640625
ants 0.06256103515625
▁were 1.5087890625
▁rec 4.15625
ru 0.00756072998046875
ited 0.00043201446533203125
▁for 4.2578125
▁at 5.98828125
▁six 6.07421875
▁two 7.796875
▁months 2.87109375
▁major 8.6875
▁pain 3.36328125
▁cent 3.609375
ers 0.0284576416015625
▁relief 14.5078125
▁in 2.90625
▁The 6.6328125
▁Israel 9.765625
. 3.21875
▁used 8.9453125
▁research 5.43359375
ers 3.40234375
▁The 4.83984375
▁De 10.03125
pression 0.27880859375
▁Module 10.40625
▁the 3.34765625
▁of 2.36328125
▁Health 7.22265625
▁Question 7.359375
naire 0.1583251953125
▁Pat 8.125
ient 0.4287109375
▁and 3.458984375
▁the 2.68359375
▁General 5.0390625
ized 1.22265625
▁An 0.132080078125
x 0.0016908645629882812
iety 0.0035724639892578125
▁Dis 1.478515625
order 0.042755126953125
▁Sc 3.04296875
ale 0.051055908203125
▁to 3.888671875
▁interview 6.8359375
▁participants 3.123046875
, 3.427734375
▁evaluate 5.875
▁answers 7.58984375
, 2.201171875
▁their 5.77734375
▁and 3.62890625
▁conduct 6.40234375
▁the 2.146484375
▁study 2.19921875
. 0.8505859375
▁specifically 9.265625
▁To 7.921875
▁evaluate 3.599609375
▁and 3.43359375
▁compare 2.40625
▁of 4.46875
▁the 1.259765625
▁prob 10.9921875
abilities 0.69482421875
▁de 4.28125
pression 0.10540771484375
▁or 5.37109375
▁anx 0.139892578125
iety 0.0008096694946289062
▁among 2.34765625
▁groups 6.76953125
, 4.01953125
▁the 2.12890625
▁diverse 11.1015625
▁the 3.931640625
▁study 4.42578125
▁used 5.484375
▁multiple 5.67578125
▁log 5.94140625
istic 0.076171875
▁regression 0.76513671875
▁analysis 1.05859375
▁and 2.626953125
▁chose 9.5
▁medical 7.01953125
▁as 5.9609375
▁mar 5.43359375
iju 0.009979248046875
ana 0.0011444091796875
▁the 3.833984375
▁group 5.3046875
. 1.7529296875
<0x0A> 1.2783203125
This 3.609375
▁control 7.86328125
▁type 7.640625
▁study 3.8203125
▁of 3.8359375
▁is 4.46484375
▁the 2.259765625
▁most 4.01171875
▁reve 8.9296875
aling 0.015960693359375
▁and 1.701171875
▁as 6.015625
▁inclus 7.73828125
ive 0.09442138671875
, 3.7578125
▁it 2.962890625
▁contains 5.375
▁direct 8.90625
▁responses 5.2265625
▁from 1.5986328125
▁a 3.5234375
▁large 1.7392578125
▁number 0.97314453125
▁of 0.2381591796875
▁All 9.1953125
▁participants 1.8310546875
. 4.046875
▁in 5.6796875
▁tools 11.6328125
▁of 2.560546875
▁the 1.84765625
▁form 6.58984375
▁question 4.98046875
na 0.61962890625
ires 0.001678466796875
▁scales 10.890625
▁and 1.931640625
▁already 9.828125
▁have 4.00390625
▁been 2.3828125
▁used 2.29296875
▁and 3.53515625
▁their 4.765625
▁proved 8.7109375
▁effic 4.703125
acy 0.0021381378173828125
▁for 3.158203125
▁collect 7.55078125
ing 0.0538330078125
▁analyt 8.1953125
ical 0.26953125
▁data 0.5068359375
. 0.63916015625
▁helps 11.421875
▁It 6.1171875
▁to 3.357421875
▁system 7.30859375
at 1.5087890625
ize 0.135498046875
▁class 9.1875
ify 0.94921875
▁and 0.8251953125
▁distinct 10.4453125
▁kinds 8.40625
▁of 0.311279296875
▁information 3.912109375
▁un 8.234375
comp 7.0
licated 0.310302734375
▁for 4.20703125
▁subsequent 7.6640625
▁services 10.6875
. 1.189453125
▁Thus 5.24609375
, 0.32763671875
▁research 4.60546875
ers 1.228515625
▁can 2.00390625
▁compare 4.828125
▁the 1.3330078125
▁effects 2.46484375
▁of 0.2034912109375
▁medic 4.734375
ations 0.74267578125
▁on 2.248046875
▁patients 2.466796875
▁of 3.71875
▁diverse 6.37109375
▁age 3.890625
▁groups 1.5654296875
, 0.7353515625
▁background 4.54296875
s 0.5361328125
, 0.4248046875
▁conditions 4.8046875
, 0.60009765625
▁physical 5.8515625
▁emot 9.875
ional 0.0245513916015625
▁states 2.26171875
, 0.6689453125
▁and 0.875
▁on 5.89453125
. 4.75390625
<0x0A> 0.87841796875
The 1.7861328125
▁analysis 5.4453125
▁so 8.609375
▁any 7.59765625
▁of 3.015625
▁human 8.1484375
▁reaction 6.94140625
▁has 5.88671875
▁a 2.51171875
▁potential 5.5703125
▁high 7.27734375
▁subject 8.046875
iveness 4.515625
▁of 2.892578125
▁and 4.234375
▁bias 4.66015625
, 2.193359375
▁especially 3.912109375
▁regarding 4.50390625
▁in 5.08203125
▁people 6.01171875
▁severe 8.25
▁and 2.57421875
▁pain 3.990234375
▁un 7.5546875
stable 4.19921875
▁condition 3.35546875
. 0.71728515625
▁emot 8.4765625
ional 0.208984375
▁Perhaps 11.96875
▁some 5.4921875
▁patients 2.75
▁tend 5.38671875
▁to 0.144775390625
▁their 6.48828125
▁ex 7.2890625
agger 0.1854248046875
ate 0.9609375
▁de 4.65625
press 2.541015625
ive 0.2474365234375
▁or 2.27734375
▁state 7.43359375
▁vice 12.4921875
▁de 5.24609375
- 7.51953125
emph 5.15234375
as 0.0865478515625
ize 0.3154296875
▁vers 13.1640625
a 2.642578125
, 2.365234375
▁serious 7.46484375
▁difficulties 6.99609375
. 2.025390625
▁the 4.0703125
▁Because 8.0703125
▁survey 9.078125
▁responses 4.66796875
▁were 2.69140625
▁thoroughly 9.1328125
▁anonymous 5.859375
, 0.57568359375
▁the 1.7939453125
▁research 2.62890625
ers 0.71533203125
▁were 1.9306640625
▁unable 3.17578125
▁to 0.1785888671875
▁carefully 8.4296875
▁analyze 1.8037109375
▁each 4.8046875
▁patient 2.5390625
’ 25.40625
s 1.1884765625
▁reaction 3.91796875
▁and 2.33984375
▁compare 4.41796875
▁it 1.80078125
▁to 1.4638671875
▁the 1.08203125
▁actual 5.19140625
▁of 5.02734375
▁states 7.42578125
▁condition 7.54296875
. 0.5927734375
▁More 6.64453125
▁accurate 4.69921875
▁could 8.046875
▁answers 9.671875
▁obtained 5.10546875
▁be 5.00390625
▁by 3.92578125
▁professional 7.6484375
▁via 9.640625
▁personal 3.994140625
▁psych 5.41796875
olog 3.009765625
ists 0.195068359375
▁communication 7.7109375
▁and 2.185546875
▁behavior 6.65234375
al 0.462158203125
▁However 9.953125
, 0.05865478515625
▁analysis 5.65625
. 4.69140625
▁this 6.171875
▁method 3.041015625
▁research 6.12109375
▁of 4.9375
▁is 3.546875
▁way 8.0234375
▁more 2.849609375
▁resource 7.44140625
- 1.2685546875
int 0.7119140625
ensive 0.0189056396484375
▁energy 11.6640625
- 1.7998046875
consum 0.76708984375
ing 0.031036376953125
. 1.37890625
<0x0A> 0.69384765625
Part 5.453125
icip 0.154052734375
ants 0.0645751953125
▁and 3.453125
▁were 4.98828125
▁rec 2.8203125
ru 0.0063018798828125
ited 0.0003349781036376953
▁for 1.4619140625
▁six 4.84765625
▁months 1.240234375
▁at 2.802734375
▁major 2.251953125
▁two 7.17578125
▁relief 8.0703125
▁pain 1.5400390625
▁cent 1.126953125
ers 0.0069122314453125
▁in 1.255859375
▁Israel 0.87646484375
. 0.59375
▁All 3.75
▁patients 1.720703125
▁experienced 5.90625
▁chron 1.9833984375
ic 0.0029125213623046875
▁at 5.59765625
▁for 6.0859375
▁pain 1.732421875
▁least 11.171875
▁ 2.029296875
3 1.5693359375
▁study 10.4375
▁The 4.09765625
▁months 7.76171875
. 2.1953125
▁included 6.171875
▁ 3.041015625
8 2.908203125
9 2.951171875
0 3.65234375
▁which 7.328125
▁participants 4.5546875
, 3.064453125
▁of 4.109375
▁ 2.904296875
4 2.22265625
7 2.572265625
4 2.703125
▁( 3.22265625
5 1.203125
9 1.955078125
%) 1.2314453125
▁treated 7.359375
▁were 3.841796875
▁with 5.5390625
▁sole 10.765625
ly 0.802734375
▁op 1.8349609375
io 0.38232421875
ids 0.51318359375
, 1.7919921875
▁( 4.859375
4 3.259765625
1 2.423828125
%) 1.4384765625
▁ 5.125
3 2.13671875
2 2.837890625
9 3.9296875
▁were 3.6171875
▁treated 2.669921875
▁with 0.57421875
▁MM 1.8203125
, 1.2744140625
▁and 0.7841796875
▁ 1.3662109375
7 3.017578125
7 2.53515625
▁( 1.7421875
8 1.6865234375
. 2.013671875
6 4.3828125
%) 0.09576416015625
▁acquired 9.484375
▁both 2.681640625
▁( 4.72265625
Fe 10.5546875
ing 4.07421875
old 0.0169525146484375
▁et 1.9140625
▁al 0.1522216796875
., 0.962890625
▁ 0.0906982421875
2 0.79248046875
0 0.005527496337890625
1 0.927734375
7 3.443359375
). 0.333251953125
▁remaining 10.7109375
▁The 5.58203125
▁ten 9.265625
▁participants 3.814453125
▁who 2.736328125
▁did 2.466796875
▁not 0.17529296875
▁receive 3.310546875
▁ph 4.09375
arma 0.1795654296875
ce 0.10162353515625
ut 0.0014066696166992188
ical 0.009674072265625
▁op 0.98095703125
io 0.08428955078125
ids 0.0618896484375
▁and 2.150390625
▁mar 3.61328125
iju 0.00638580322265625
ana 0.00075531005859375
▁medical 5.50390625
▁were 2.8828125
▁from 4.57421875
▁with 7.140625
dra 3.169921875
wn 0.003570556640625
▁the 3.515625
▁analysis 4.57421875
▁in 4.5390625
▁the 1.65625
▁research 4.609375
. 1.68359375
▁Therefore 5.72265625
, 0.13427734375
▁it 3.552734375
▁is 1.544921875
▁not 2.306640625
▁possible 2.275390625
▁to 0.322998046875
▁compreh 6.71484375
ens 0.338134765625
ively 0.018707275390625
▁compare 2.3125
▁taking 11.234375
▁patients 5.4765625
▁with 2.251953125
▁those 3.73828125
▁medic 7.25390625
ations 0.50927734375
▁who 3.6015625
▁do 3.16796875
▁not 0.66796875
. 2.35546875
<0x0A> 0.53369140625
The 1.4248046875
▁conducted 7.03515625
▁a 3.81640625
▁study 2.681640625
▁correlation 10.125
▁of 2.28125
▁type 7.3125
▁research 4.92578125
▁with 3.705078125
▁variable 9.3671875
▁measures 6.22265625
. 2.587890625
▁It 3.265625
▁evaluated 6.16796875
▁the 0.98095703125
▁of 2.9296875
▁inter 7.15234375
dep 3.544921875
end 0.004055023193359375
ence 0.034393310546875
▁factors 6.8671875
▁various 7.7421875
▁that 6.23828125
▁affected 5.62890625
▁the 0.830078125
▁physical 7.19921875
▁and 0.93115234375
▁emot 0.669921875
ional 0.003376007080078125
▁condition 2.640625
▁of 0.350830078125
▁patients 0.77099609375
▁experien 3.95703125
cing 0.00012242794036865234
▁chron 0.5517578125
ic 0.0010433197021484375
▁pain 0.316650390625
. 0.61767578125
▁For 4.59765625
▁example 1.6689453125
, 0.0728759765625
▁the 1.4775390625
▁survey 6.30859375
▁showed 4.2890625
▁that 0.6181640625
▁the 1.7099609375
▁ratio 8.09375
▁of 0.3916015625
▁female 4.6796875
▁patients 1.0859375
▁was 1.8349609375
▁higher 1.6298828125
▁remark 12.0
ably 0.0328369140625
▁in 2.732421875
▁the 1.5810546875
▁group 1.5234375
▁op 6.921875
i 2.8203125
ates 0.0185546875
▁compared 3.162109375
▁to 0.441650390625
▁the 1.09375
▁group 1.044921875
. 2.677734375
▁MM 2.240234375
▁In 7.84765625
▁turn 5.55859375
, 0.12371826171875
▁people 6.15625
▁on 5.1875
▁op 2.931640625
i 0.494140625
ates 0.003421783447265625
▁were 1.10546875
▁more 1.404296875
▁likely 1.3212890625
▁to 0.290771484375
▁report 4.13671875
▁de 2.283203125
press 2.1953125
ive 0.0166015625
▁major 8.9453125
▁dis 4.6171875
orders 0.22509765625
. 1.5009765625
<0x0A> 2.724609375
The 1.3330078125
▁question 5.328125
na 1.3271484375
ires 0.0003905296325683594
▁used 2.810546875
▁different 6.53515625
▁variable 7.109375
▁measures 1.2978515625
▁to 1.8525390625
▁collect 3.87890625
▁information 1.890625
. 1.7646484375
▁For 2.7890625
▁example 0.2418212890625
, 0.041168212890625
▁included 8.1953125
▁it 7.07421875
▁compreh 7.56640625
ensive 0.08758544921875
▁data 4.10546875
: 5.34765625
▁so 5.87109375
cio 0.322998046875
- 0.42919921875
dem 0.1463623046875
ographic 0.101318359375
▁gender 7.7578125
, 0.6630859375
▁country 6.40625
, 1.392578125
▁type 4.24609375
▁age 6.23828125
, 0.58544921875
▁residence 6.99609375
▁of 4.1875
▁( 5.72265625
urban 5.6015625
/ 2.7109375
r 0.0631103515625
ural 0.00146484375
), 0.456787109375
▁of 4.8984375
▁years 5.46875
▁education 3.494140625
, 0.278564453125
▁and 2.232421875
▁employ 4.40234375
ment 0.01515960693359375
▁status 1.302734375
. 0.322265625
▁Pat 5.1640625
ients 0.1688232421875
▁also 3.35546875
▁were 2.38671875
▁asked 0.84765625
▁about 1.5146484375
▁their 0.9755859375
▁history 5.09765625
▁medical 5.125
▁over 8.4609375
▁the 1.2978515625
▁years 2.771484375
▁and 2.2421875
▁current 3.693359375
▁the 4.5703125
▁of 2.150390625
▁presence 7.6640625
▁severe 7.41796875
▁any 6.59375
▁such 6.44140625
▁dise 3.0546875
ases 0.0007748603820800781
▁as 1.0703125
▁heart 2.486328125
▁failure 2.986328125
, 0.2010498046875
▁ar 4.375
th 0.22021484375
rit 0.042816162109375
is 0.00826263427734375
, 0.10760498046875
▁and 2.091796875
▁di 1.9140625
ab 0.0037937164306640625
etes 0.00751495361328125
, 2.443359375
▁so 5.234375
▁third 11.109375
▁on 5.5390625
. 2.76171875
▁The 2.681640625
▁of 4.0234375
▁measure 7.109375
▁the 3.099609375
▁question 4.234375
naire 0.5302734375
▁indicated 7.46875
▁was 5.40234375
▁by 7.01171875
▁information 7.55859375
▁on 2.484375
▁any 5.71484375
▁twelve 11.359375
- 2.9296875
month 0.2269287109375
▁and 4.671875
▁lifetime 3.63671875
▁and 4.609375
▁drug 6.1953125
▁alco 6.8359375
hol 0.0014781951904296875
▁consumption 3.328125
. 0.8310546875
▁In 3.947265625
▁addition 0.98876953125
, 0.145263671875
▁the 1.4482421875
▁record 8.1484375
▁included 3.32421875
▁pain 5.0078125
▁a 5.453125
▁measurement 6.734375
▁scale 3.595703125
▁from 4.05078125
▁ 0.833984375
0 0.5771484375
▁to 0.5576171875
▁ 0.07562255859375
1 0.2783203125
0 0.08477783203125
▁to 4.76171875
▁evaluate 2.3515625
▁feelings 6.83203125
▁dis 7.25390625
com 0.71435546875
fort 0.003940582275390625
▁during 4.56640625
▁the 0.92236328125
▁last 1.7177734375
▁month 1.7822265625
. 0.78564453125
<0x0A> 0.5595703125
Am 6.859375
ong 0.01397705078125
▁all 2.74609375
▁participants 2.359375
▁in 4.0625
▁the 0.412109375
▁ 5.26171875
4 2.625
2 2.74609375
. 2.474609375
2 2.599609375
% 0.65576171875
▁study 6.640625
, 2.986328125
▁suffered 6.73828125
▁from 0.75439453125
▁de 1.8994140625
pression 0.220947265625
, 1.482421875
▁and 1.923828125
▁experienced 7.1640625
▁ 2.650390625
3 1.8896484375
7 2.53125
% 2.599609375
▁excess 8.9765625
ive 0.131103515625
▁anx 0.5205078125
iety 0.0028057098388671875
. 0.5712890625
▁The 1.6123046875
▁pl 10.84375
ur 1.6103515625
ality 0.0013408660888671875
▁de 5.30078125
press 2.185546875
ive 0.03155517578125
▁of 3.970703125
▁dis 5.921875
orders 0.2073974609375
▁among 3.275390625
▁patients 1.451171875
▁in 3.818359375
▁the 0.66748046875
▁op 3.859375
i 1.7666015625
ates 0.00940704345703125
, 3.99609375
▁medical 4.16015625
▁mar 0.89599609375
iju 0.00899505615234375
ana 0.00023996829986572266
, 0.912109375
▁and 0.2421875
▁mixed 6.23046875
▁OP 9.2109375
MM 8.9140625
▁number 10.4296875
ed 3.076171875
▁groups 7.7734375
▁ 3.654296875
5 2.357421875
7 2.642578125
. 0.82177734375
1 1.861328125
%, 0.54345703125
▁respectively 5.47265625
. 0.420166015625
▁ 3.9375
2 1.8408203125
2 2.078125
. 0.14892578125
3 2.46484375
%, 1.5634765625
▁ 1.2177734375
5 3.240234375
1 2.765625
. 0.12744140625
4 2.265625
%, 0.263671875
▁and 0.43701171875
▁The 4.953125
▁pl 4.89453125
ur 0.041748046875
ality 8.225440979003906e-05
▁of 1.0009765625
▁anx 1.064453125
iety 0.010467529296875
▁contained 10.1171875
▁among 2.6875
▁ 3.703125
4 1.818359375
8 2.40625
. 0.07757568359375
4 2.583984375
% 1.083984375
▁OP 6.796875
▁patients 8.7890625
, 0.64794921875
▁ 1.0546875
2 1.33984375
1 2.224609375
. 0.067138671875
5 2.435546875
% 0.46923828125
▁among 4.16015625
▁MM 1.4384765625
▁patients 0.85888671875
, 0.06585693359375
▁ 1.6845703125
3 2.0078125
8 2.76953125
. 0.10943603515625
7 2.3125
% 0.047332763671875
▁and 3.56640625
▁among 3.65625
▁OP 5.8671875
MM 0.498291015625
▁participants 5.3515625
. 1.08984375
▁who 8.7109375
▁Pat 8.8984375
ients 0.11663818359375
▁took 5.59375
▁strong 8.5
▁op 2.18359375
i 1.3837890625
ates 0.005260467529296875
▁were 2.9140625
▁t 7.6640625
ended 0.289794921875
▁to 0.181396484375
▁place 9.703125
▁their 3.5703125
▁pain 3.64453125
▁on 2.61328125
▁scale 6.80859375
▁a 5.734375
▁of 5.203125
▁ 1.1162109375
9 2.759765625
▁to 2.259765625
▁ 0.1063232421875
1 0.08782958984375
0 0.123046875
▁( 2.96875
Fe 3.5390625
ing 0.015472412109375
old 0.0029888153076171875
▁et 0.09503173828125
▁al 0.01496124267578125
., 0.022216796875
▁They 8.8046875
▁were 1.599609375
▁ 2.666015625
2 1.9736328125
0 2.212890625
1 4.61328125
7 0.62548828125
). 0.239501953125
▁also 5.05078125
▁an 6.4140625
gu 6.2890625
ished 1.935546875
▁em 6.68359375
otion 0.0132598876953125
ally 0.034393310546875
▁and 2.0625
▁react 7.27734375
ed 0.2010498046875
▁rad 9.859375
ically 0.0118408203125
▁neg 5.6171875
atively 0.002605438232421875
▁to 0.94482421875
▁almost 6.203125
▁survey 10.5
▁all 5.19921875
▁questions 4.2265625
. 1.2041015625
▁Pat 5.953125
ients 0.033203125
▁who 2.30078125
▁took 1.3603515625
▁only 3.72265625
▁MM 1.70703125
▁or 3.14453125
▁mixed 3.439453125
▁medic 3.3828125
ations 0.253173828125
▁course 11.0
▁a 5.48046875
▁significantly 4.29296875
▁had 7.46875
▁more 2.505859375
▁stable 4.67578125
▁state 3.69140625
▁emot 2.59375
ional 0.487548828125
▁cop 7.83984375
ed 6.26171875
▁and 4.0078125
▁with 5.3828125
▁pain 4.6875
▁more 3.818359375
▁manage 6.734375
able 0.564453125
. 1.1767578125
<0x0A> 0.6982421875
One 5.71484375
▁the 4.4140625
▁of 2.48046875
▁major 4.15234375
▁limitations 6.0
▁is 3.18359375
▁the 0.8935546875
▁ins 5.83984375
u 0.032379150390625
fficient 0.10345458984375
ly 5.37890625
▁high 4.12890625
▁rate 5.52734375
, 5.27734375
▁response 6.6875
▁instead 10.9921875
▁ 5.40625
5 2.154296875
7 2.11328125
% 1.4892578125
▁of 1.1044921875
▁ 3.03515625
7 2.97265625
0 2.3828125
% 1.2216796875
▁( 3.62890625
Fe 1.0185546875
ing 0.007598876953125
old 0.0020351409912109375
▁et 0.01558685302734375
▁al 0.0236358642578125
., 0.016754150390625
▁ 0.51171875
2 0.00690460205078125
0 0.0022716522216796875
1 0.005199432373046875
7 0.0217132568359375
). 0.216064453125
▁It 3.814453125
▁can 4.7109375
▁be 0.66015625
▁fairly 8.3359375
▁explained 4.62109375
▁by 0.58935546875
▁the 0.626953125
▁focus 7.828125
▁weak 12.03125
▁of 3.013671875
▁respond 4.92578125
ents 0.253173828125
▁who 3.259765625
▁have 4.5234375
▁overcome 8.2578125
▁sens 9.3671875
ations 2.96484375
▁severe 6.125
▁pain 1.654296875
▁de 7.890625
press 2.412109375
ive 0.10791015625
▁and 1.83984375
▁episodes 10.3046875
. 2.86328125
▁is 6.8203125
▁It 6.77734375
▁clear 8.8828125
▁not 6.09765625
▁how 6.21484375
▁to 2.20703125
▁use 5.09765625
▁statistics 7.109375
, 2.830078125
▁these 7.40625
▁they 7.0
▁as 5.69921875
▁still 7.4140625
▁may 5.7734375
▁be 1.3720703125
▁relevant 5.14453125
▁the 4.09375
▁for 4.60546875
▁overall 6.86328125
▁analysis 2.91796875
. 1.138671875
